The High Court of Delhi will hear arguments this week in another patent assertion targeting a Chinese brand in India
The Qi portfolio will offer licences to IP rights owned by a quartet of companies, including Philips and Robert Bosch
Fractus, a Barcelona-based antenna tech developer, comes up short in its bid to secure a key European injunction against the Chinese mobile maker
New ranking celebrates the US automaker’s advances in autonomous driving, but there are more obstacles to overcome
Expanded role sees Ray Millien tasked with leading team that identifies early stage auto start-ups with potential to become tier 1 or 2 suppliers
There are significant gains for branded pharma in the agreement. But in several other areas, China has made commitments it already meets
The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.
Guiding principle behind pre-Christmas statement was need for uniform rules for all patents, Nicholas Matich explained at ABA event, where he also spoke about new agency 101 initiative following SCOTUS refusal to hear key eligibility case
Oral hearings before the EPO’s Boards of Appeal may have a big impact on the European Cas9 landscape
Qihoo 360’s Huang Jing took $65,000 in payoffs as he directed work to a law firm and an IP agency, court hears
USPTO records show that Big Blue off-loaded hundreds of assets to Xperi late last year in its latest major deal
The Chinese IP office knocked out several claims from the sole patent owned by the NPE that was deemed essential and infringed in a recent Nanjing FRAND ruling
Decision to join follows the acquisition of open source giant Red Hat and is a major boost to the defensive patent operator
Chinese company says patent and trade secrets litigation launched by North Carolina-based Celgard in a US court constitutes "slander of the company’s goodwill"
Decision not to hear Athena dispute will disappoint many, but may prove catalyst to reinvigorate stalled efforts to reform US patent eligibility regime